UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 2, 2007
KMG Chemicals, Inc.
(Exact name of registrant as specified in its charter)
|
TEXAS |
|
000-29278 |
|
75-2640529 |
|
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
of incorporation) |
|
File Number) |
|
Identification No.) |
|
10611 Harwin Drive, Suite 402, Houston, Texas |
|
77036 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code 713-600-3800
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On March 2, 2007, KMG Chemicals, Inc. issued a press release announcing the operating results for the second quarter of fiscal year 2007. A copy of the press release is furnished as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
99.1 Press Release, dated March 2, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
KMG Chemicals, Inc. |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ John V. Sobchak |
|
|
Date: March 2, 2007 |
|
|
John V. Sobchak, |
|
|
|
|
|
Chief Financial Officer |
|
|
|